About Technology Issues FAQ

Links

Official Page

Single-Agent Monoclonal Antibody Efficacy in Bulky Non-Hodgkin's Lymphoma: Results of a Phase II Trial of Rituximab

Single-Agent Monoclonal Antibody Efficacy in Bulky Non-Hodgkin's Lymphoma: Results of a Phase II Trial of Rituximab — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.